Patent & IP news for September 6, 2010

Monday miscellany from ipkitten.blogspot.com

If you are sending the IPKat any documents that you are hoping he will use, can you please help him by making them as easily accessible as possible by not including them in copy-protected files ...

Share via E–mail | Twitter | Facebook

Microsoft Files Another Patent Reexamination Request Against i4i from www.patentspostgrant.com

The seemingly never ending Microsoft v. i4i dispute continued on to the doorstep of the Supreme Court last week. In 2009, Microsoft was found to have infringed i4i’s 5,787,449 patent, which allegedly ...

Share via E–mail | Twitter | Facebook

BGH on enablement: disclosure may be enabling without being novelty destroying from ipkitten.blogspot.com

The American Ethicon, Inc. (part of the Johnson & Johnson group of companies) sued an unnamed defendant based on the German part of EP 337 612 before the Landgericht Düsseldorf. The patent in suit claims an ...

Share via E–mail | Twitter | Facebook

Inventing the 21st Century exhibition opens to the public from britishlibrary.typepad.co.uk

It's been a long road, and now the British Library's Inventing the 21st Century exhibition is open to the public to see. Here's the logo for the exhibition. The BBC has an ...

Share via E–mail | Twitter | Facebook

Pharma Cases Dominate New USPTO Obviousness Examination Guidelines from www.pharmapatentsblog.com

On September 1, 2010 the USPTO issued an update to the Obviousness Examination Guidelines that were promulgated after the Supreme Court's 2007 KSR decision. The new Guidelines are intended to supplement, not replace, the ...

Share via E–mail | Twitter | Facebook

Inventing the 21st Century the book from britishlibrary.typepad.co.uk

To accompany our Inventing the 21st Century exhibition I have written a book with the same title, which is published today. It's a paperback priced at £9.95. It has 50 stories about interesting ...

Share via E–mail | Twitter | Facebook

More on Paul Allen and Interval from ipbiz.blogspot.com

The end of piece on the Allen matter by Chris O'Brien states:

Beyond the legal fight, I'm even more troubled the patents were awarded in the first place. The functions covered by the ...

Share via E–mail | Twitter | Facebook

The Twitter trademark from ipbiz.blogspot.com

Within the Twitter guidelines on trademark: This document is designed to help you use our marks without having to worry about negotiating an agreement with us or talking to our lawyers.

Of the text: That ...

Share via E–mail | Twitter | Facebook

The End of the Venture Capital Era? from ipbiz.blogspot.com

Back in 2006, IPBiz quoted Christopher Sugden of Edison Venture Fund (Lawrenceville, NJ): "patents are not why we are investing."

Flash forward to 2010 and IPFinance has the text:

For some time now, there have ...

Share via E–mail | Twitter | Facebook

EU Patent - Background Note On Machine Translations from www.ipjur.com

In an earlier posting I had reported that, on the first day of the Belgian EU Presidency, the EU Commission had published a Proposal for a Council Regulation (EU) on the translation arrangements for the ...

Share via E–mail | Twitter | Facebook

The High Cost of Marketing and Selling an Invention from hallingblog.com

Inventors and critics of the patent system often ignore or are ignorant of the high cost of marketing and selling a new product embodying an invention.   I discussed this cost in Invention- A Financial Analysis ...

Share via E–mail | Twitter | Facebook

Abbott’s HIV/AIDS Drug Patents Challenged by PUBPAT from ipwatchdog.com

I am skeptical about the prospects for invalidating patents on drugs, particularly important or blockbuster drugs. I also question whether anti-patent do-gooders in the biotech and pharma space are really causing more harm than good ...

Share via E–mail | Twitter | Facebook

Off-Topic: Research- What Does It Demand? from spicyipindia.blogspot.com

In the last post, I had penned a few rudimentary non-novel obvious thoughts on what it takes to nurture a culture of innovation based on Prof.Vijay Govindarajan’s (VG) work. In this post, I ...

Share via E–mail | Twitter | Facebook

BPAI substantially rigid not elastic from allthingspros.blogspot.com

Takeaway: The BPAI smacked down an Examiner's unreasonably broad interpretation of “substantially rigid.” The Examiner took the untenable position that “substantially rigid” read on “elastic.” The Examiner's justification was that the claim limitation ...

Share via E–mail | Twitter | Facebook

Eli Lilly & Co. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2010) from www.patentdocs.org

By Kevin E. Noonan -- The old proverb "success has many fathers, while failure is an orphan" comes to mind when considering the Federal Circuit's decision in Eli Lilly & Co. v. Teva Pharmaceuticals USA, Inc ...

Share via E–mail | Twitter | Facebook